Analysts Offer Insights on Healthcare Companies: Agios Pharma (NASDAQ: AGIO) and Agilent (NYSE: A)

By Carrie Williams

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agios Pharma (NASDAQ: AGIO) and Agilent (NYSE: A) with bullish sentiments.

Agios Pharma (NASDAQ: AGIO)

In a report released today, Alethia Young from Credit Suisse maintained a Buy rating on Agios Pharma (NASDAQ: AGIO), with a price target of $95. The company’s shares closed yesterday at $83.46, close to its 52-week high of $87.00.

According to TipRanks.com, Young is a 3-star analyst with an average return of 1.1% and a 45.1% success rate. Young covers the Healthcare sector, focusing on stocks such as Alexion Pharmaceuticals, Sarepta Therapeutics, and Coherus Biosciences.

Agios Pharma has an analyst consensus of Strong Buy, with a price target consensus of $89.33.

Agilent (NYSE: A)

In a report released today, Steve Beuchaw from Morgan Stanley maintained a Buy rating on Agilent (NYSE: A), with a price target of $91. The company’s shares closed yesterday at $66.64.

Beuchaw has an average return of 10.2% when recommending Agilent.

According to TipRanks.com, Beuchaw is ranked #684 out of 4766 analysts.

Agilent has an analyst consensus of Strong Buy, with a price target consensus of $81.67.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.